Suppr超能文献

新型活动性测试评估遗传性视网膜营养不良患者的功能性视力。

Novel mobility test to assess functional vision in patients with inherited retinal dystrophies.

机构信息

Spark Therapeutics, Inc., Philadelphia, Pennsylvania, USA.

Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

出版信息

Clin Exp Ophthalmol. 2018 Apr;46(3):247-259. doi: 10.1111/ceo.13022. Epub 2017 Aug 31.

Abstract

IMPORTANCE

This novel endpoint tracks functional vision changes in patients with inherited retinal dystrophies (IRDs) over time.

BACKGROUND

The aims of the study were to determine whether a multi-luminance mobility test (MLMT) can detect functional vision changes over time in subjects with IRDs and to assess natural history and potential effects of investigational agents.

DESIGN

This is a prospective, observational study.

PARTICIPANTS

Sixty-two subjects were enrolled. Sixty (29 normal sighted and 31 visually impaired) were eligible; 54 (28 visually impaired and 26 normal-sighted) completed all testing visits.

METHODS

Subjects navigated MLMT courses three times over 1 year. At each visit, subjects completed testing using individual eyes, and both eyes, at up to nine standardized, increasing luminance levels (range 1 to 400 lux). Accuracy and speed were evaluated and compared with visual acuity (VA), visual field (VF) and a visual function questionnaire.

MAIN OUTCOME MEASURES

Accuracy and speed of normal and visually impaired subjects on MLMT, and reliability and content validity of MLMT were the main outcome measures.

RESULTS

MLMT distinguished normal-sighted from visually impaired subjects. All control subjects passed all MLMT attempts at all tested light levels. Visually impaired subjects' performance varied widely; some declined over 1 year. Performance declined markedly below certain VA and VF thresholds. Concordance on performance on two baseline visits was high: correlations for accuracy were 94% and 98% for lowest common and highest common lux levels.

CONCLUSIONS AND RELEVANCE

MLMT differentiated visually impaired from control populations and, in visually impaired subjects, identified a range of performances; and tracked performance declines over time, consistent with these progressive conditions.

摘要

重要性

本新型终点可追踪遗传性视网膜疾病(IRD)患者的功能视力随时间的变化。

背景

本研究旨在确定多亮度移动测试(MLMT)是否能在IRD 患者随时间推移检测到功能视力变化,并评估自然史和研究药物的潜在影响。

设计

这是一项前瞻性、观察性研究。

参与者

共纳入 62 名受试者。60 名(29 名视力正常和 31 名视力障碍)符合入选条件;54 名(28 名视力障碍和 26 名视力正常)完成了所有测试访视。

方法

受试者在 1 年内进行了 3 次 MLMT 测试。每次访视,受试者使用单眼和双眼,在最多 9 个标准化的、递增亮度水平(范围 1 至 400 lux)下完成测试。评估准确性和速度,并与视力(VA)、视野(VF)和视觉功能问卷进行比较。

主要结果测量

MLMT 中正常视力和视力障碍受试者的准确性和速度,以及 MLMT 的可靠性和内容效度是主要结果测量。

结果

MLMT 区分了视力正常和视力障碍的受试者。所有对照受试者均通过了所有 MLMT 尝试,达到了所有测试的光强度。视力障碍受试者的表现差异很大;一些人在 1 年内下降。在某些 VA 和 VF 阈值以下,表现明显下降。两次基线访视的表现一致性很高:最低和最高共同 lux 水平的准确性相关性分别为 94%和 98%。

结论和相关性

MLMT 区分了视力障碍和对照人群,在视力障碍受试者中,识别了一系列表现;并随时间追踪到表现下降,与这些进行性疾病一致。

相似文献

8
Mobility scooter driving ability in visually impaired individuals.视障人士驾驶电动轮椅的能力。
Disabil Rehabil. 2018 Jun;40(12):1372-1378. doi: 10.1080/09638288.2017.1295471. Epub 2017 Mar 21.

引用本文的文献

3
In Vivo Cone Photoreceptor Topography of the Human Foveola.人中央凹小凹的体内视锥光感受器地形图
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):13. doi: 10.1167/iovs.66.11.13.
9
Digital health and wearable devices for retinal disease monitoring.用于视网膜疾病监测的数字健康与可穿戴设备。
Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):279-289. doi: 10.1007/s00417-024-06634-3. Epub 2024 Sep 19.

本文引用的文献

7

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验